Presidents


Nicola Mozzillo

Nicola Mozzillo
Honorary President





Paolo A. Ascierto

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy



Igor Puzanov

Igor Puzanov
Director Early Phase Clinical Trials Program, Co-Leader Experimental Therapeutics Program, Chief Melanoma Section Department of Medicine Roswell Park Cancer Institute, Buffalo, NY



Ena Wang

Ena Wang
Acting CRO
Research Chief, Translational Medicine Division, Research Branch, Sidra Medical and Research Center, Doha, Qatar





Scientific Board


Sanjiv Agarwala

Sanjiv Agarwala
Chief of Medical oncology and Hematology, St. Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania



Paolo A. Ascierto

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy



Carlo Bifulco

Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon



Sandra Demaria

Sandra Demaria
Weill Cornell medical College, New York, NY




Reinhard Dummer

Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland




Bernard A. Fox

Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon



Jerome Galon

Jerome Galon
INSERM (National Institute of Health and Medical Research), Paris, France




Claus Garbe

Claus Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany



Giuseppe Masucci

Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden



Michael Postow

Michael Postow
Memorial Sloan Kettering Cancer Center, New York




Igor Puzanov

Igor Puzanov
Director Early Phase Clinical Trials Program, Co-Leader Experimental Therapeutics Program, Chief Melanoma Section Department of Medicine Roswell Park Cancer Institute, Buffalo, NY



Magdalena Thurin

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland



Ena Wang

Ena Wang
Acting CRO
Research Chief, Translational Medicine Division, Research Branch, Sidra Medical and Research Center, Doha, Qatar




 


For information please contact info@melanomabridge.org